Illumina Inc (ILMN) Stock Analysis
Verdict: HOLD
Structural NGS dominance meets clinical demand tailwinds, but aggressive insider selling and premium valuation cap immediate upside.
Investment score: 64/100
Analysis as of
Is Illumina Inc stock worth reviewing? AI model thesis
The model sees a fundamental bottoming process complete, but warns of technical resistance near $170-$177. Recent insider selling suggests the smart money is trimming into this rally.
7-factor investment score
- Valuation: 42/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 72/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 58/100 (weight 15%)
Illumina Inc opportunities and risks
What speaks for ILMN
- Clinical Sequencing Inflection
What speaks against ILMN
- Aggressive Insider/Activist Divestment
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ILMN | 29.5x | 5.7x | 18.7x | 67.7% | 19.4% | 4.0% |
| TMO | 25.5x | 3.9x | 19.3x | 39.4% | 15.2% | 3.9% |
| DHR | 34.7x | 5.2x | 21.2x | 60.7% | 14.9% | 4.1% |
| WAT | 66.2x | 6.3x | 31.1x | 55.0% | 11.9% | 1.1% |
| A | 25.4x | 5.0x | 19.1x | 53.0% | 19.6% | 3.5% |
| IQV | 21.1x | 1.7x | 12.2x | 26.1% | 8.3% | 8.8% |
| Peer median | 25.5x | 5.0x | 19.3x | 53.0% | 14.9% | 3.9% |
Frequently asked questions about Illumina Inc (ILMN)
Is ILMN stock a good investment?
The cached TradeMates AI model rates Illumina Inc as HOLD with an investment score of 64/100. The model sees a fundamental bottoming process complete, but warns of technical resistance near $170-$177. Recent insider selling suggests the smart money is trimming into this rally. This is algorithmic model output, not personal investment advice.
Is ILMN stock a buy?
The TradeMates model verdict for ILMN is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.